These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36698902)

  • 41. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adrenal insufficiency as part of X-linked adrenoleukodystrophy].
    Enikeeva SR; Chugunov IS; Kareva MA; Kurkina MV; Zakharova EY; Michailova SV; Bezlepkina OB; Peterkova VA; Mokrysheva NG
    Probl Endokrinol (Mosk); 2023 Dec; 70(3):83-92. PubMed ID: 39069776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis.
    Wiesinger C; Eichler FS; Berger J
    Appl Clin Genet; 2015; 8():109-21. PubMed ID: 25999754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.
    Sandlers Y; Moser AB; Hubbard WC; Kratz LE; Jones RO; Raymond GV
    Mol Genet Metab; 2012 Mar; 105(3):416-20. PubMed ID: 22197596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Family Perspectives on Newborn Screening for X-Linked Adrenoleukodystrophy in California.
    Schwan K; Youngblom J; Weisiger K; Kianmahd J; Waggoner R; Fanos J
    Int J Neonatal Screen; 2019 Dec; 5(4):42. PubMed ID: 33073000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy.
    Gupta AO; Raymond G; Pierpont EI; Kemp S; McIvor RS; Rayannavar A; Miller B; Lund TC; Orchard PJ
    Expert Opin Biol Ther; 2022 Sep; 22(9):1151-1162. PubMed ID: 36107226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Clinical Spectrum of Adrenoleukodystrophy at a Portuguese Tertiary Hospital: Case Series and Review of Literature.
    Menezes C; Losa A; Mosca S; de Carvalho Vaz A; Figueiredo CM; Garrido C; Borges T; Borges Correia J
    Cureus; 2024 Jan; 16(1):e52496. PubMed ID: 38370996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy.
    Rattay TW; Rautenberg M; Söhn AS; Hengel H; Traschütz A; Röben B; Hayer SN; Schüle R; Wiethoff S; Zeltner L; Haack TB; Cegan A; Schöls L; Schleicher E; Peter A
    Sci Rep; 2020 Sep; 10(1):15093. PubMed ID: 32934269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans.
    Curiel J; Steinberg SJ; Bright S; Snowden A; Moser AB; Eichler F; Dubbs HA; Hacia JG; Ely JJ; Bezner J; Gean A; Vanderver A
    Mol Genet Metab; 2017 Nov; 122(3):130-133. PubMed ID: 28919002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
    Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
    Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.
    Schlüter A; Espinosa L; Fourcade S; Galino J; López E; Ilieva E; Morató L; Asheuer M; Cook T; McLaren A; Reid J; Kelly F; Bates S; Aubourg P; Galea E; Pujol A
    Hum Mol Genet; 2012 Mar; 21(5):1062-77. PubMed ID: 22095690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients.
    Zhu Z; Genchev GZ; Wang Y; Ji W; Zhang X; Lu H; Sriswasdi S; Tian G
    Orphanet J Rare Dis; 2023 May; 18(1):102. PubMed ID: 37189159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular species profiles of plasma ceramides in different clinical types of X-linked adrenoleukodystrophy.
    Morito K; Shimizu R; Ali H; Shimada A; Miyazaki T; Takahashi N; Rahman MM; Tsuji K; Shimozawa N; Nakao M; Sano S; Azuma M; Nanjundan M; Kogure K; Tanaka T
    J Med Invest; 2023; 70(3.4):403-410. PubMed ID: 37940524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug discovery for X-linked adrenoleukodystrophy: An unbiased screen for compounds that lower very long-chain fatty acids.
    Moser AB; Liu Y; Shi X; Schrifl U; Hiebler S; Fatemi A; Braverman NE; Steinberg SJ; Watkins PA
    J Cell Biochem; 2021 Oct; 122(10):1337-1349. PubMed ID: 34056752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies.
    Ma CY; Li C; Zhou X; Zhang Z; Jiang H; Liu H; Chen HJ; Tse HF; Liao C; Lian Q
    Biomed Pharmacother; 2021 Nov; 143():112214. PubMed ID: 34560537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Screening for carrier and prenatal diagnosis of X-linked adrenoleukodystrophy].
    Wang AH; Bao XH; Xiong H; Pan H; Wu Y; Zhang YH; Shi CY; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):345-9. PubMed ID: 15924749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advanced Diagnostic System and Introduction of Newborn Screening of Adrenoleukodystrophy and Peroxisomal Disorders in Japan.
    Shimozawa N; Takashima S; Kawai H; Kubota K; Sasai H; Orii K; Ogawa M; Ohnishi H
    Int J Neonatal Screen; 2021 Aug; 7(3):. PubMed ID: 34449525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Two Novel Mutations of
    Dong B; Lv W; Xu L; Zhao Y; Sun X; Wang Z; Cheng B; Fu Z; Wang Y
    Int J Endocrinol; 2022; 2022():5479781. PubMed ID: 35479665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method.
    Hubbard WC; Moser AB; Liu AC; Jones RO; Steinberg SJ; Lorey F; Panny SR; Vogt RF; Macaya D; Turgeon CT; Tortorelli S; Raymond GV
    Mol Genet Metab; 2009 Jul; 97(3):212-20. PubMed ID: 19423374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.